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The F220C and F45L rhodopsin 
mutations identified in retinitis 
pigmentosa patients do not cause 
pathology in mice
Tylor R. Lewis1, Camilla R. Shores2, Martha A. Cady1, Ying Hao1, Vadim Y. Arshavsky1,4 & 
Marie E. Burns2,3 ✉
Retinitis pigmentosa is a retinal degenerative disease that leads to blindness through photoreceptor 
loss. Rhodopsin is the most frequently mutated protein in this disease. While many rhodopsin 
mutations have well-understood consequences that lead to cell death, the disease association of 
several rhodopsin mutations identified in retinitis pigmentosa patients, including F220C and F45L, has 
been disputed. In this study, we generated two knockin mouse lines bearing each of these mutations. 
We did not observe any photoreceptor degeneration in either heterozygous or homozygous animals 
of either line. F220C mice exhibited minor disruptions of photoreceptor outer segment dimensions 
without any mislocalization of outer segment proteins, whereas photoreceptors of F45L mice were 
normal. Suction electrode recordings from individual photoreceptors of both mutant lines showed 
normal flash sensitivity and photoresponse kinetics. Taken together, these data suggest that neither 
the F220C nor F45L mutation has pathological consequences in mice and, therefore, may not be 
causative of retinitis pigmentosa in humans.
Retinitis pigmentosa (RP) is a retinal degenerative disease characterized by a progressive loss of photo-
receptors1. With a worldwide prevalence of about 1 in 4,000 people, there are an estimated 2 million people 
affected2. Approximately one third of autosomal dominant RP (adRP) cases are caused by mutations in the G 
protein-coupled receptor (GPCR) rhodopsin, with over 150 different causative mutations currently identified3. 
The majority of these mutations lead to defects in rhodopsin folding, trafficking, chromophore binding or trans-
ducin activation; yet, there are mutations that are currently unclassified with no known biochemical or cellular 
defects4.
One unclassified rhodopsin mutation, F220C, was described in 19935 in a study analyzing the sequences of 
rhodopsin genes from 88 patients/families with a positive family history of adRP. Another retinitis pigmentosa 
patient bearing the F220C mutant allele was subsequently identified6. However, a different study7 found that 
a similar F220L rhodopsin mutation did not co-segregate with adRP. Further, both F220C and F220L mutant 
rhodopsins have been predicted to have normal protein stability and folding in a computational study8, although 
more recent work found that the F220C mutant has a minor trafficking defect in mammalian cell culture9.
Another unclassified rhodopsin mutation, F45L, was first described in 199110 in a study analyzing 161 unre-
lated patients with adRP, where it was present in a single patient and not in any of 118 normal subjects. Seven 
family members of this patient were subsequently analyzed and the F45L mutation completely co-segregated 
with disease in all of them (including four affected and three unaffected family members). The presence of the 
F45L mutation was subsequently identified in a 34 year-old adRP patient (although the defects in visual function 
reported in this patient were relatively mild)11, a 73 year-old patient with severely affected vision12 and two addi-
tional patients whose age and pathology were not reported6. However, there are two observations that conflict 
with reports that the F45L allele is pathogenic. First, an adRP patient bearing the F45L mutation inherited this 
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mutation from an asymptomatic father13. Second, eight carriers of the F45L mutation were all free of any signs 
of adRP14. When analyzed in cell culture, F45L mutant rhodopsin appeared to traffic normally to the plasma 
membrane13,15. One property that F45L rhodopsin shares with F220C rhodopsin is that they both behaved as 
monomers in in vitro assays in which WT rhodopsin behaved as a dimer16.
Given the conflicting evidence surrounding the molecular defects and pathogenicity of F220C and F45L rho-
dopsin mutations, we generated knockin mice bearing each mutation. We conducted a comprehensive analysis 
of both heterozygous and homozygous mice from each line, which included various microscopic techniques and 
single cell suction electrode recordings. Our experiments revealed no evidence of photoreceptor degeneration 
associated with either mutation, and rod photoreceptors of both lines had normal light sensitivities and photo-
response kinetics. These data challenge the causative role of each mutation in human adRP patients.
Results
Generation of F220C and F45L knockin mice. To study the pathogenicity of these rhodopsin mutations, 
we generated knockin mice using CRISPR/Cas9 methodology for both F220C (c.659 T > G mutation in exon 3 of 
Rho) and F45L (c.133 T > C mutation in exon 1 of Rho) rhodopsin mutations (Fig. 1). We used pronuclear injec-
tions of short guide RNAs along with both Cas9 mRNA and/or Cas9 protein and repair oligonucleotides con-
taining either the c.659 T > G or c.133 T > C mutation. Potential founders were sequenced to verify the desired 
nucleotide substitution and the integrity of the remaining gene. Mice were then outcrossed with C57BL/6-J mice 
for at least three generations before analysis.
Characterization of the F220C mouse. To address whether F220C mutant rhodopsin can cause photore-
ceptor degeneration, we analyzed thin retinal cross-sections from heterozygous F220C knockin mice (F220C/+ ; 
as in adRP patients), homozygous mice (F220C/F220C) and their WT littermates (Fig. 2). We observed no major 
difference in either gross photoreceptor morphology or the number of photoreceptor nuclei across these geno-
types at either 1 month or 15 months of age. The only subtle difference was the occasional appearance of empty 
spaces between outer segments of mutant mice. These data show that the F220C rhodopsin mutation does not 
cause photoreceptor degeneration in mice.
We next sought to identify whether there may be any defects in localization of rhodopsin or other outer seg-
ment proteins within mutant rods. Figure 3 shows that rhodopsin localization was normal in both hetero- and 
Figure 1. Generation of knockin mouse lines bearing the F220C and F45L rhodopsin mutations. The coding 
sequence of mouse Rho consists of five exons. (Left) The F45L mutation is caused by a c.133 T > C mutation 
in exon 1. A 200-nt long repair oligonucleotide (oligo) was used (purple) in conjunction with the depicted (in 
green) single small guide RNA (gRNA) and Cas9 mRNA and protein to generate this allele. (Right) The F220C 
mutation is caused by a c.659 T > G mutation in exon 3. A 102-nt long repair oligonucleotide (oligo) was used 
(purple) in conjunction with the depicted (in green) single small guide RNA (gRNA) and Cas9 protein to 
generate this allele. Sequencing of DNA from WT, heterozygous, and homozygous mice reveals the correct 
knockin mutation generated for both the F45L and F220C alleles.
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homozygous mice, as was localization of several other representative outer segment proteins – CNGβ1, ABCA4, 
R9AP and PRCD – the latter previously shown to rely on rhodopsin for transport to the outer segment17.
To analyze photoreceptor ultrastructure, we performed transmission electron microscopy (TEM) (Fig. 4), 
focusing primarily on photoreceptor outer segments because rhodopsin is the main protein component of these 
organelles18 and outer segment disc organization is often affected in other mouse adRP models19,20. We used tan-
nic acid as a membrane-contrasting reagent, as it preferentially stains membranes of newly formed “open” discs21, 
thereby allowing us to reveal any defect in disc morphogenesis that could be affected by abnormal rhodopsin 
transport or incorporation into the outer segment membranes. However, TEM analysis showed that outer seg-
ments, including new disc membranes, appeared essentially normal in both hetero- and homozygous mice. The 
only trend we observed was a slightly smaller outer segment diameter of homozygous F220C rods.
To follow-up on the latter observation, we performed TEM on tangential sections of outer segments (Fig. 5a). 
This allowed us to measure the outer segment diameters of a very large number of rods (750 outer segments 
across 5 WT and homozygous F220C animals) to reliably identify a possible reduction in outer segment size. 
This quantification revealed that, while the diameter of WT outer segments was 1.40 ± 0.01 µm, the diameter of 
F220C/F220C outer segments was 1.34 ± 0.01 µm (p < 0.0001). Therefore, the F220C mutation causes a small 
reduction in outer segment diameter.
To determine how this small reduction in outer segment diameter affected the total rhodopsin content of the 
retina, we dissected dark-adapted eyecups under dim red light and used difference spectroscopy22 to quantify 
rhodopsin in F220C/F220C and WT eyecups (Fig. 5b). Interestingly, the total rhodopsin content of the F220C/
F220C eyecups was no different than that of wild-type (p = 0.7109). We then sought to measure outer segment 
lengths to determine whether there may be a compensatory effect that offsets the smaller diameter of F220C 
Figure 2. F220C mice do not exhibit photoreceptor degeneration. (a) Light microscopy images of 0.5 μm 
thin retinal plastic sections stained with methylene blue. Depicted are WT, heterozygous (F220C/+), and 
homozygous (F220C/F220C) retinas at 1 month and 15 months of age. Scale bar is 10 μm. (b) The number 
of photoreceptor nuclei are quantified over a 100 μm length of retina at 500 μm intervals away from the optic 
nerve (ON) at 1 month and 15 months of age (n = 3 for each genotype at each age). There are no statistically 
significant differences among genotypes with two-way ANOVA at either age.
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homozygous outer segments and thus keeps rhodopsin content the same (Fig. 5c). Indeed, when measured on 
plastic retinal cross-sections, outer segments of F220C/F220C mice did appear slightly longer than in WT mice 
(34.7 ± 0.6 µm vs. 31.1 ± 0.5 µm; p = 0.011).
We next performed single cell suction electrode recordings on rods of 8–13 week old age-matched wildtype, 
heterozygote and homozygote littermates. Rod responses to calibrated light flashes were very similar in mice of 
all three genotypes (Table 1; Fig. 6). Rod sensitivity to light was unaffected by the F220C mutation: the amplitude 
of the response to a single activated rhodopsin (SPR) was indistinguishable between lines and the flash strength 
needed to generate a half-maximal response (Io) was virtually identical (Table 1). The time constants of recovery 
for dim flash responses (𝜏rec) and bright flash responses (𝜏D) were likewise indistinguishable (Table 1; Fig. 6). 
Importantly, there was no significant difference in the effective collecting areas of wild-type and homozygous 
F220C rods (Table 1), which is likely due to the compensatory effect created by an increase in length and decrease 
in diameter, as reported above. Taken together, we observed no significant differences between WT, heterozygous 
and homozygous F220C rods.
Characterization of the F45L mouse. To address whether F45L mutant rhodopsin can cause photore-
ceptor degeneration, we analyzed thin retinal cross-sections from heterozygous F45L knockin mice (F45L/+ ; 
as in adRP patients), homozygous mice (F45L/F45L) and their WT littermates (Fig. 7). We observed no major 
Figure 3. F220C mice do not exhibit mislocalization of photoreceptor outer segment proteins. 
Immunofluorescent staining of photoreceptor outer segment-specific proteins in WT, heterozygous (F220C/+), 
and homozygous (F220C/F220C) retinas at 1 month of age. Both disc-specific (rhodopsin, ABCA4, PRCD, 
R9AP) and outer segment plasma membrane-specific (CNGβ1) proteins are analyzed (red). Nuclei are stained 
with Hoechst (blue). Scale bar is 10 μm.
5Scientific RepoRtS |         (2020) 10:7538  | https://doi.org/10.1038/s41598-020-64437-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
difference in the number of photoreceptor nuclei across these genotypes at either 1 month or 6 months of age. 
Further, we did not observe any gross morphological differences between genotypes of any age. These data show 
that the F45L rhodopsin mutation does not cause photoreceptor degeneration in mice. We next investigated local-
ization of rhodopsin and two other representative outer segment proteins (ABCA4 and PRCD) within mutant 
rods (Fig. 8) and found that their localization was normal in both hetero- and homozygous F45L mice.
To analyze photoreceptor ultrastructure, we performed transmission electron microscopy (TEM) (Fig. 9), 
focusing primarily on photoreceptor outer segments. This analysis showed that outer segments, including new 
disc membranes, appeared normal in both F45L/+ and F45L/F45L mice.
Lastly, we performed single cell suction electrode recordings on rods of 9–12 week old age-matched wildtype, 
heterozygote and homozygote littermates, as described above. Rod responses to calibrated light flashes were iden-
tical in mice of all three genotypes (Table 2; Fig. 10).
Discussion
The data obtained in this study demonstrate that neither the F220C nor the F45L mutation in rhodopsin has 
pathological consequences in knockin mouse models. The F220C mutation displayed a minor abnormal-
ity in the outer segment size, while F45L photoreceptors were completely normal. Since all well-characterized 
disease-causing rhodopsin mutations lead to photoreceptor degeneration in mice23,24, it is unlikely that the F220C 
and F45L mutations are directly causal in producing adRP. The apparent discrepancy between our mouse data 
and the notion that these two mutations are causative of adRP can be resolved in a number of ways. As described 
in the introduction, neither mutation has complete co-segregation with adRP6,13,14. The fact that both mutations 
have been found in healthy humans has been consistently used as an argument against the notion that these muta-
tions are causative of disease, which to a great degree motivated our study.
Figure 4. Rod outer segments of F220C mice do not exhibit any gross ultrastructural defects. TEM images 
of the base of photoreceptor outer segments from WT, heterozygous (F220C/+), and homozygous (F220C/
F220C) mice are shown at 1 month and 15 months of age. Sections are stained with tannic acid to intensely label 
nascent, open discs at the base of the outer segment. Scale bar is 0.5 μm.
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Figure 5. Rod outer segments of F220C mice are slightly thinner and longer. (a) TEM of a tangential 
section through the photoreceptor outer segment layer of WT and homozygous F220C mice. Scale bar is 1 
μm. Diameters of 150 outer segments were measured in 5 different mice for a total of 750 outer segments 
per genotype. Diameters were grouped within 0.02 μm bins to plot the relative frequency of outer segment 
diameters ranging from 1.0 μm to 1.8 μm. The relative frequency plot is overlaid with Gaussian distribution 
curves for WT (solid line) and F220C/F220C (dashed line) datasets. Unpaired t-test reveals a statistically 
significant difference (p < 0.0001) between the outer segment diameters of WT (1.40 ± 0.01 µm) and F220C/
F220C (1.34 ± 0.01 µm) mice. (b) Total rhodopsin content of dissected eyecups was determined by difference 
spectroscopy22. Unpaired t-test depicts no statistically significant difference (p = 0.7109) in rhodopsin content 
between WT and homozygous F220C mice at 10 months of age (n = 3 for each genotype). (c) Photoreceptor 
outer segment lengths were measured from five different regions of each of three different mice per genotype 
at 1 month of age. Unpaired t-test reveals a statistically significant difference (p = 0.011) between the outer 
segment lengths of WT (34.7 ± 0.6 µm) and F220C/F220C (31.1 ± 0.5 µm) mice.
Dark current 
(pA)
SPR amplitude 
(pA)
Dim flash 
recovery τrec 
(ms)
Dim flash 
integration 
time (ms)
Flash Sensitivity 
Io (photons 
μm−2)
Saturating flash 
recovery τD 
(ms)
Collecting area 
(µm2)
WT 13.3 ± 0.7 (25) 0.50 ± 0.05 (22) 190 ± 12 (23) 225 ± 20 (25) 59 ± 6 (25) 178 ± 10 (25) 0.37 ± 0.08 (22)
F220C/ + 14.3 ± 0.7 (14) 0.59 ± 0.07 (14) 163 ± 22 (14) 227 ± 21 (14) 61 ± 8 (14) 173 ± 17 (14) 0.35 ± 0.04 (14)
F220C/F220C 13.0 ± 0.7 (17) 0.54 ± 0.09 (11) 180 ± 21 (16) 229 ± 22 (16) 58 ± 8 (16) 191 ± 9 (16) 0.38 ± 0.06 (11)
Table 1. Single cell recordings reveal normal response kinetics in F220C rhodopsin mutant rods.
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There are two potential explanations as to why the F45L or F220C mutant alleles were identified in adRP 
patients. A trivial explanation is that neither allele is pathogenic and they were coincidently present in the indi-
viduals analyzed in the original genetic studies13,25. This explanation is consistent with a relatively high frequency 
of these alleles in the general population25 and a modest number of subjects analyzed in the original studies. 
Another possibility is that F45L and F220C are modifying alleles, which interact with other non-rhodopsin 
mutations to cause retinal degeneration in adRP patients. Examples of gene interactions affecting photoreceptor 
degeneration and other ciliopathies have been reported in several studies26–30. Indeed, most studies of patients 
bearing the F45L and F220C alleles only analyzed the sequence of the rhodopsin gene5,10,11,13,14. Therefore, in con-
junction with our data, it is reasonable to suggest that the F220C and F45L substitutions in rhodopsin are most 
likely polymorphisms that are either benign or modifying alleles.
Despite a lack of photoreceptor degeneration in either F220C or F45L mice, we did observe a small morpho-
logical defect associated with the F220C mutation. Outer segments of these mice have a slightly reduced diameter 
(1.34 µm vs. 1.40 µm in WT). One potential explanation for this phenomenon is a reduced ability of F220C rho-
dopsin to correctly fold in the biosynthetic membranes, such that the amount of rhodopsin delivered to the outer 
segment is slightly reduced. Based on the measured reduction of the outer segment diameter and the correspond-
ing reduction in the disc surface area in F220C mice, we estimate that the amount of rhodopsin transported to the 
outer segment is approximately 92% of WT. This explanation is consistent with a recent finding that the F220C 
rhodopsin mutant has a minor trafficking defect in cultured mammalian cells, with only 86% of mutant protein 
trafficked to the plasma membrane9.
The phenotype of F220C mice can be compared to that of rhodopsin hemizygous mice whose outer seg-
ment diameter is only 1.1–1.2 µm, corresponding to about 60% of the WT outer segment rhodopsin content31,32. 
Rhodopsin hemizygous mice exhibit slow photoreceptor degeneration with 1–2 rows of photoreceptor nuclei 
reported to be lost by 3 months of age33. Together, these results suggest that while photoreceptors can tolerate a 
small decrease in the rhodopsin content of discs (e.g. the 8% decrease observed in F220C mutant mice), there is 
some level of reduced rhodopsin content that ultimately causes pathology.
The reduced diameter of F220C homozygous outer segments is offset by an increase in length by approx-
imately 11%, which results in no detectable change in the total rhodopsin content of the retina as measured 
by difference spectroscopy or collecting area measurements obtained from suction electrode recordings. These 
data support the idea that the photoreceptor outer segment has some innate capacity to regulate its propensity 
to capture photons, perhaps related to other reported mechanisms of outer segment length control34 or through 
Figure 6. F220C rhodopsin mutant photoreceptors do not exhibit any electrophysiological defects. (a) Suction 
electrode recordings of families of responses to flashes that ranged from 13–51,000 photons/μm2 by factors 
of 2–4. Flashes were delivered at t = 0 s. (b) Population average single photon responses calculated from WT 
(n = 22), F220C/+ (n = 14) and F220C/F220C (n = 11) rods. Light shading represents SEM. (c) Relationship 
between the time that a bright flash response remained in saturation and the natural log of the number of 
photoexcited rhodopsins (R*) produced by the flash. The initial slope reflects the dominant time constant of 
recovery for bright flashes, which was the same for mutant and WT rods. Error bars represent SEM.
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regulation of disc shedding35. Interestingly, such compensation is not observed in the rhodopsin hemizygous 
mouse whose outer segments are both thinner and shorter than in WT mice32,33.
Lastly, a recent study found that both F220C and F45L mutant rhodopsin behave as monomers in in vitro 
reconstitution assays, whereas WT rhodopsin behaves as a dimer. Given that GPCR dimerization has previously 
been shown to regulate receptor folding36–41 and trafficking42–45, it is intriguing to believe that the phenotype of 
the F220C mutant could be due to issues with rhodopsin dimerization. Indeed, the only study to address the 
effect of disrupted rhodopsin dimerization in intact photoreceptors reported that inhibitory peptides46, shown to 
mildly disrupt rhodopsin dimerization in vitro47, caused rhodopsin mislocalization46. Yet, another recent study 
in mammalian cells suggested that F220C mutant rhodopsin does not affect its dimerization9. While rhodop-
sin dimerization within disc membranes has been shown through atomic-force microscopy48 and cryo-electron 
microscopy49, there is currently no assay for analyzing rhodopsin dimerization during folding and trafficking, 
precluding us for identifying whether the F220C mutation in rhodopsin does indeed affect its dimerization in 
vivo, and, subsequently, what the role of rhodopsin dimerization in intact photoreceptors is.
Figure 7. F45L mice do not exhibit photoreceptor degeneration. (a) Light microscopy images of 0.5 μm thin 
retinal plastic sections stained with methylene blue. Depicted are WT, heterozygous (F45L/+), and homozygous 
(F45L/F45L) retinas at 1 month and 6 months of age. Scale bars are 10 μm. (b) The number of photoreceptor 
nuclei are quantified over a 100 μm length of retina at 500 μm intervals away from the optic nerve (ON) 
at 1 month and 6 months of age (n = 3 for each genotype at each age). There are no statistically significant 
differences among genotypes with two-way ANOVA at either age.
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Materials and Methods
Animals. All methods with regard to mice handling were carried out in accordance with relevant guide-
lines and regulations. F220C mutant mice were generated through the Duke Transgenic and Knockout Mouse 
Facility through pronuclear injections of C57BL/6 J mouse embryos with 2 ng/µl of a short guide RNA (5′ 
TCGTCATCTTCTTCTGCTAT GGG 3′), 8 ng/µl of a 102-nucleotide repair oligonucleotide containing the 
c.659 T > G mutation to knock-in the F220C allele (5′ T GTC ATC TAC ATG TTC GTG GTC CAC TTC ACC 
Figure 8. F45L mice do not exhibit mislocalization of photoreceptor outer segment proteins. 
Immunofluorescent staining of photoreceptor outer segment disc-specific proteins (red) in WT, heterozygous 
(F45L/+), and homozygous (F45L/F45L) retinas at 1 month of age. Nuclei are stained with Hoechst (blue). Scale 
bar is 10 μm.
Figure 9. Rod outer segments of F45L mice do not exhibit any gross ultrastructural defects. TEM images of the 
base of photoreceptor outer segments from WT, heterozygous (F45L/+), and homozygous (F45L/F45L) mice 
are shown at 1 month of age. Sections are stained with tannic acid to intensely label nascent, open discs at the 
base of the outer segment. Scale bar is 0.5 μm.
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ATT CCT ATG ATC GTC ATC TGC TTC TGC TAT GGC CAG CTG GTC TTC ACA GTC AAG GAG GTA 
TGA GCA GGG GG 3′), 2 ng/µl Cas9 mRNA, and 2 ng/µl Cas9 protein. Potential founders were genotyped for 
successful knock-in through sequencing of a 491-base pair PCR product of the rhodopsin locus using primers (5′ 
GCAGAGCTGCGTGGTCAAGTGG 3′; 5′ CCTTCTGAGTGGTGGCTGACTCC 3′). F45L mutant mice were 
generated through the Duke Transgenic and Knockout Mouse Facility through pronuclear injections of C57BL/6 J 
mouse embryos with 200 ng/µl of a short guide RNA (5′ GAACATGTACGCTGCCAGCA TGG 3′), 0.649 ng/
µl of a 200-nucleotide repair oligonucleotide containing the c.133 T > C mutation to knock-in the F220C allele 
(5′ CCC TTC TCC AAC GTC ACA GGC GTG GTG CGG AGC CCC TTC GAG CAG CCG CAG TAC TAC 
CTG GCG GAA CCA TGG CAG TTC TCT ATG CTG GCA GCG TAC ATG CTC CTG CTC ATC GTG CTG 
GGC TTC CCC ATC AAC TTC CTC ACG CTC TAC GTC ACC GTA CAG CAC AAG AAG CTG CGC ACA 
CCC CTC AAC TAC ATC CTG CTC AA 3′), and 8 µM Cas9 protein. Potential founders were genotyped for 
successful knock-in through sequencing of a 596-base pair PCR product of the rhodopsin locus using primers 
(5′ GCCTCCACCCGATGTCACC 3′; 5′ CCCTCGAGATTACAGCCTG 3′). Mice bearing successful knock-ins 
were outcrossed to C57BL/6 J mice for several generations. All mice were genotyped to ensure that they did not 
contain either the rd850 or rd151 mutations commonly found in inbred mouse strains. All mice were housed under 
a 12/12 hour diurnal light cycle. Littermate WT, heterozygous, and homozygous mutant mice were used for all 
experiments.
Immunofluorescence. Anesthetized mice were transcardially perfused with a fixative solution contain-
ing 4% paraformaldehyde in 80 mM PIPES (pH 6.8), 5 mM EGTA, and 2 mM MgCl2. Eyes were enucleated and 
post-fixed in the same solution for two hours at room temperature. After fixation, dissected eyecups were embed-
ded in 2.5% low-melt agarose (Precisionary) and cut by a Vibratome (VT1200S; Leica) into 100 µm thick slices 
as described previously52. Agarose sections were blocked in PBS containing 5% donkey serum and 0.5% Triton 
X-100 for 1 h at room temperature before staining with primary antibody in blocking buffer overnight at 4 °C. 
After primary antibody staining, sections were washed three times in PBS and incubated with secondary antibody 
in blocking buffer overnight at 4 °C. Finally, sections were washed three times in PBS and nuclei were stained 
with 10 µg/ml Hoechst (H3569; Thermo Fisher Scientific) for 30 min at room temperature. Finally, sections were 
washed three times in PBS, and mounted onto slides with Immu-Mount (Thermo) and coverslipped. Images were 
taken with a confocal microscope (Eclipse 90i and A1 confocal scanner; Nikon) with a 60× objective (1.4 NA 
Plan Apochromat VC; Nikon) using Nikon NIS-Elements software. Image analysis and processing was performed 
with ImageJ.
Antibodies. For immunofluorescence imaging, commercial primary antibodies included: polyclonal goat 
anti-human ABCA4, 1:2000 (Everest Biotech) and monoclonal mouse anti-bovine RHO (1D4), 1:2000 (Abcam)53. 
The polyclonal rabbit anti-mouse CNGβ1, 1:500, was a generous gift from Dr. Steven Pittler. The polyclonal rabbit 
anti-mouse R9AP, 1:2500, was a generous gift from Dr. Stefan Heller54. The polyclonal rabbit anti-mouse PRCD, 
1:2000, was previously generated by the Arshavsky lab55. The commercial secondary antibodies included donkey 
anti-goat, donkey anti-mouse, and donkey anti-rabbit conjugated to Alexa Fluor 488 or 568, 1:1000 (Invitrogen).
Histological techniques and transmission electron microscopy. Fixation and processing of mouse 
eyes for light microscopy of plastic sections was performed as described previously21. Anesthetized mice were 
transcardially perfused with 2% paraformaldehyde, 2% glutaraldehyde, and 0.05% calcium chloride in 50 mM 
MOPS (pH 7.4) resulting in exsanguination. Enucleated eyes were fixed for an additional 2 h in the same fixation 
solution at room temperature. To obtain semi-thin plastic retinal sections, eyecups were cut in half through the 
optic nerve, dehydrated with ethanol, and embedded in EMbed 812 (Electron Microscopy Sciences). Embedded 
retinal cross sections were cut through the optic nerve in 500 nm slices and stained with methylene blue for light 
microscopy as previously described56. Images were taken with a confocal microscope (Eclipse 90i and A1 confocal 
scanner; Nikon) with a 60× objective (1.4 NA Plan Apochromat VC; Nikon) using Nikon NIS-Elements software. 
Image analysis and processing was performed with ImageJ.
For TEM involving tannic acid staining, eyes were fixed as described above. Eyecups were dissected from 
fixed eyes, embedded in 2.5% low-melt agarose (Precisionary), and cut into 200 µm thick slices on a Vibratome 
(VT1200S; Leica)21. Agarose sections were stained with 1% tannic acid (Electron Microscopy Sciences) and 1% 
uranyl acetate (Electron Microscopy Sciences), gradually dehydrated with ethanol, and infiltrated and embedded 
in Spurr’s resin (Electron Microscopy Sciences). For TEM involving tangential sections of outer segments, eyes 
were fixed as described above. Dissected eyecups were flatmounted, dehydrated with ethanol, and embedded in 
EMbed 812 (Electron Microscopy Sciences). For all TEM, 70 nm sections were cut, placed on copper grids, and 
counterstained with 2% uranyl acetate and 3.5% lead citrate (19314; Ted Pella). The samples were imaged on a 
JEM-1400 electron microscope (JEOL) at 60 kV with a digital camera (Orius; Gatan).
Dark current 
(pA)
SPR amplitude 
(pA)
Dim flash 
recovery τrec 
(ms)
Dim flash 
integration 
time (ms)
Flash Sensitivity 
Io (photons 
μm−2)
Saturating flash 
recovery τD 
(ms)
Collecting area 
(µm2)
WT 13.2 ± 0.7 (22) 0.57 ± 0.05 (22) 184 ± 10 (22) 242 ± 13 (22) 44 ± 3 (22) 154 ± 8 (22) 0.50 ± 0.05 (22)
F45L/+ 12.7 ± 0.6 (27) 0.61 ± 0.06 (14) 186 ± 10 (27) 247 ± 17 (27) 40 ± 2 (27) 173 ± 8 (26) 0.55 ± 0.07 (17)
F45L/F45L 13.1 ± 06 (30) 0.61 ± 0.04 (19) 177 ± 12 (30) 255 ± 20 (30) 44 ± 2 (30) 170 ± 8 (28) 0.46 ± 0.05 (19)
Table 2. Single cell recordings reveal normal response kinetics in F45L rhodopsin mutant rods.
1 1Scientific RepoRtS |         (2020) 10:7538  | https://doi.org/10.1038/s41598-020-64437-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Suction electrode recordings. Animals used for electrophysiological analysis were cared for and han-
dled in accordance with a protocol approved by the Institutional Animal Care and Use Committees of UC 
Davis. Suction electrode recordings from the outer segments of intact mouse rods were performed as previously 
described57. Briefly, mice 2–3 months of age were dark-adapted overnight, euthanized, and their retinas were 
dissected and stored on ice in L-15 medium supplemented with 10 mM glucose. Recordings were performed 
in oxygenated, bicarbonate buffered Locke’s solution supplemented with 10 mM glucose at 35–37 °C. A suction 
pipette containing HEPES-buffered Locke’s solution (pH 7.4) recorded the electrical responses to brief (10 ms, 
500 nm) flashes of calibrated strength, which were amplified (Axopatch 200B; Molecular Devices), filtered at 
30 Hz with an eight-pole Bessel (Frequency Devices), and digitized at 200 Hz using custom-written acquisition 
procedures in IgorPro (Wavemetrics). Responses to a large number (>30) of dim flashes were averaged and 
used to determine the mean time to peak and integration time (time integral of the response divided by the peak 
amplitude). Variance-to-mean analysis of the dim flash responses was used to calculate the average single-photon 
response (SPR) and effective collecting areas for each cell, and saturating flash responses were used to calculate 
the dominant time constant of recovery (τD), as previously described57–59.
Rhodopsin difference spectra. Mice were dark-adapted overnight before removal of cornea and lens dur-
ing dim red light. Eyecups were lysed in 600 µl of 2% octyl glucoside with protease inhibitor (cOmplete; Sigma 
Aldrich) and sonicated 3 times each of 5 seconds. Lysates were centrifuged at 10,000 × g for 10 minutes and the 
rhodopsin concentration of the supernatant was measured by difference spectroscopy22. Hydroxylamine (25 mM; 
pH 7.5) was added to 100 μl of lysate and the initial spectra recorded from 300 to 700 nm using a DU800 spec-
trophotometer (Beckman). The cuvette sample was then bleached with a 100-W halogen lamp for 60 s before 
taking the second spectrum reading. The difference in the absorbance at 500 nm was used to calculate rhodopsin 
concentration, using the extinction coefficient of 40,500 M−1 ·cm−1.
Quantification and statistical analysis. To assess photoreceptor degeneration, we counted photore-
ceptor nuclei in 100 μm boxes at 500 μm intervals from the optic nerve spanning 2000 μm in each direction for 
three mice of each genotype at each age, as previously described60. Two-way ANOVA (with respect to genotype 
and location) was performed to assess any statistical differences between genotypes. To measure photoreceptor 
diameter, the diameter of 150 outer segments was measured in each of 5 mice for each genotype for a total of 
Figure 10. F45L rhodopsin mutant photoreceptors do not exhibit any electrophysiological defects. (a) Suction 
electrode recordings of families of responses to flashes that ranged from 6–50,000 photons/μm2 by factors 
of 2–4. Flashes were delivered at t = 0 s. (b) Population average single photon responses calculated from WT 
(n = 22), F45L/+ (n = 14) and F45L/F45L (n = 19) rods. Light shading represents SEM. (c) Relationship 
between the time that a bright flash response remained in saturation and the natural log of the number of 
photoexcited rhodopsins (R*) produced by the flash. The initial slope reflects the dominant time constant of 
recovery for bright flashes, which was the same for mutant and WT rods. Error bars represent SEM.
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750 outer segments measured per genotype. A normal Gaussian distribution was fit to each genotype. Unpaired, 
two-tailed t-test (assuming equal variances) t-test was performed to assess any statistical differences between 
genotypes. To determine the total rhodopsin content of eyecups, difference spectra were taken from each of 
three dissected eyecups per genotype. Unpaired, two-tailed t-test (assuming equal variances) was performed 
to assess any statistical differences between genotypes. To quantify outer segment length, the lengths of outer 
segments in five regions across the retina were measured of each of three different retinal sections per genotype. 
Unpaired, two-tailed t-test (assuming equal variances) was performed to assess any statistical differences between 
genotypes. For all experiments, significance is labeled as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. 
Non-significant values are unlabeled. Data is represented as mean ± standard error of the mean.
Data availability
All data generated or analyzed during this study are included in this published article and available from authors 
on reasonable request.
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